Allergan announces positive topline Phase 3 results for presbyopia therapeutic
April 5th 2022According to the company, the VIRGO trial evaluated the safety and efficacy of the investigational twice-daily administration of pilocarpine HCl ophthalmic solution 1.25% in adults with presbyopia. The trial met its primary efficacy endpoint, the company noted.
Read More
Ocugen announces first patient dosed in Phase 1/2 clinical trial for gene therapy candidate OCU400
April 5th 2022According to the company, the modifier gene therapy candidate is for the treatment of retinitis pigmentosa resulting from mutations in the nuclear receptor subfamily 2 group E member 3 and Rhodopsin genes.
Read More
Artificial retinal device mimics human optical illusions
April 4th 2022Investigators at the International Center for Materials Nanoarchitectonics have developed the first-ever artificial retinal device that increases the edge contrast between lighter and darker areas of an image, using ionic migration and interaction within solid.
Read More
ACMG Foundation for Genetic and Genomic Medicine presents fellowship awards
March 30th 2022The American College of Medical Genetics and Genomics Foundation for Genetic and Genomic Medicine grants its Next Generation Fellowship Awards to promising early-career professionals in a range of medical genetics and genomics specialties. The awards were presented at the 2022 ACMG Clinical Genetics Meeting.
Read More
Scientists eye up gene required for survival of an important retinal neuron
March 23rd 2022A team of investigators at the Okinawa Institute of Science and Technology Graduate University in Japan have identified a gene necessary for the survival of retinal ganglion cells – a class of neurons located in the retina that are critical for vision.
Read More
Study: Retina a potential biomarker for reduced brain matter
March 18th 2022Researchers from the Department of Ophthalmology at the University Hospital Bonn and Deutsches Zentrum für Neurodegenerative Erkrankungen suggest that assessments of the eye’s retina could help to detect a loss of brain substance, i. e. “brain atrophy.” The findings are based on data from the Rhineland Study.
Read More